Thursday, 26 December 2019

China Cancer Screening Market Status, Key Trends, Growth Factors, Value Chain and Key Players

China’s demand for cancer screening has grown at a fast pace in the past decade. Cancer is one of the most significant healthcare burdens in China. The Chinese economy maintains a high pace of growth stimulated by the consecutive increase in capital investment. The cancer screening market in China is expected to reach USD 1.5 Bn by 2023 at 14 % CAGR.

The cancer screening market in China is classified by end users, screening type and applications. By end users, it is further classified into hospitals, laboratories and independent physicians and clinics. By screening type it is classified into laboratory, genetic, biopsy, imaging and endoscopy testing. By application type, it is further classified into lung, breast, melanoma, kidney and colorectal cancer.

 Request for Sample @ https://www.kdmarketinsights.com/sample/3280

Key growth factors
Rise in the population along with an increase in the patient pool and favourable government policies is a key driver for the market. Also, there is an increase in the aging population, growing levels of pollution and a more sedentary lifestyle.

Threats and key players
Providing drugs at lower prices along with ensuring affordability as well as accessibility will be a major threat for the region. Transparency in medical treatment is being been demanded by people, hence, provision of accurate and proper treatment will be a disguised opportunity.

The key players operating in the valve market are Quest Diagnostics, Hologic Inc., Qiagen, F. Hoffmann-La Roche AG and Abbott Laboratories.
Get the Complete Research Report with TOC @:
China Cancer Screening Market
Table of Contents:

Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary

Chapter 2: Cancer screening market in China - market overview
2.1. China market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. China - market drivers and challenges
2.3. Value chain analysis - industrial valve market in China
2.4. Porter’s five forces analysis

Chapter 3. Cancer screening market in China - by end users
3.1. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. Laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. Independent physicians and clinics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 4. Cancer screening market in China - by screening type
4.1. Laboratory testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. Genetic testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. Imaging testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. Biopsy testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5. Endoscopy testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 5. Cancer screening market in China - by application
5.1. Lung cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. Breast cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. Melanoma cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. Kidney cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5. Colorectal cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 6: Competitive landscape
6.1. Quest Diagnostics
6.1. a. Company snapshot
6.1. b. Product offerings
6.1. c. Growth strategies
6.1. d. Initiatives
6.1. e. Geographical presence
6.1. f. Key numbers
6.2. Hologic Inc.
6.3. Qiagen
6.4. F. Hoffmann-La Roche AG
6.5. Abbott Laboratories

Chapter 7: Conclusion
Chapter 8: Appendix
8.1. List of tables
8.2. Assumptions
8.3. Research and methodology
8.4. About Netscribes Inc.
Continue….

Check for Discount @ https://www.kdmarketinsights.com/discount/3280

About Us:

KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Research, you always have the choice of getting customized report free of cost (up to 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500 companies and leading advisory firms.

Contact Us:

KD Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: info@kdmarketinsights.com
Website: www.kdmarketinsights.com

No comments:

Post a comment